← Feed

GANNON STEVEN

SEC Form 4 insider
Xenon Pharmaceuticals Inc. ($XENE)
1 thesis · first seen Aug 13, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$XENESEC Form 4bearish
GANNON STEVEN · Xenon Pharmaceuticals Inc. · 3h agono track record yet
Sold 10,000 @ $64.06 avg · $640,550 · 2026-08-11

Form 4: GANNON STEVEN sold XENE

GANNON STEVEN (Director at Xenon Pharmaceuticals Inc.) reported an open-market sale of 10,000 shares of XENE at an average $64.06, roughly $640,550, in a Form 4 filed 2026-08-13.

View filing on SEC.gov →

End of results.